Understand the source comparison
Peptide Therapy Practitioners Clinical Protocol Guide: Protocol Comparison
Reconstitution Technique Direct injection onto powder, room-temp bacteriostatic water, no pressure equalisation Angled wall injection, pre-chilled bacteriostatic water (2–8°C), air volume equalisation pre-reconstitution High-compliance method reduces denaturat
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Reconstitution Technique
- Direct injection onto powder, room-temp bacteriostatic water, no pressure equalisation
- Angled wall injection, pre-chilled bacteriostatic water (2–8°C), air volume equalisation pre-reconstitution
- High-compliance method reduces denaturation by 8–12% and prevents backflow contamination. Critical for multi-draw vials
- Storage Temperature Control
- Household refrigerator (unmonitored), estimated 2–8°C
- Pharmaceutical-grade refrigerator with continuous data logging, alarm thresholds at 2°C/8°C
- Temperature excursions >8°C for >30 min trigger measurable degradation. Unmonitored storage is the #1 avoidable protocol failure
- Dosing Calculation Method
- Direct µg/kg scaling from literature without overfill adjustment
- Verify actual peptide mass via CoA, calculate concentration post-reconstitution accounting for 10–15% overfill
- Overfill variance introduces 10–14% dosing error when ignored. CoA verification is mandatory for reproducible results
- Draw Syringe Selection
- Standard 1mL Luer-lock syringe (0.1mL graduations)
- Insulin syringe with 0.01mL graduations for draws <0.3mL
- Sub-0.2mL draws with 0.1mL-graduated syringes introduce ±10% variance. Insulin syringes are required for precision
- Shelf Life Management
- 28-day guideline applied universally
- 28-day maximum with daily visual inspection + potency verification at day 14 via third-party assay if available
- Peptides with Met/Cys/Trp residues degrade faster than 28-day standard. Mid-cycle verification catches early degradation